Edition: India  
 
> >

Teva Pharm to market medical cannabis inhaler in Israel

Reuters India Monday, 28 November 2016
JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: WBAL - < > Embed

News video: Video: Diversity a top concern for Maryland Medical Cannabis Commission

Video: Diversity a top concern for Maryland Medical Cannabis Commission 02:09

Maryland's Medical Cannabis Commission announced on Monday that it is hiring a diversity consultant.

Recent related news

PreveCeutical Medical hails deal with cannabis producer, which will boost its Sol-Gel programme

Health sciences group PreveCeutical Medical Inc (CSE:PREV, OTCQB:PRVCF) says its Sol-Gel programme has received a big boost - as it struck a research and...
Proactive Investors - Business


You Might Like


Other recent news in Health

Republicans see political necessity in HEALTH CARE effortMany drug companies fail to conduct timely safety CHECKS on medicines after FDA approval
AP FACT CHECK: Trump and the fog over pre-existing maladiesHere's how you can control diabetes in NAVRATRI

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter